2xtl
From Proteopedia
(Difference between revisions)
m (Protected "2xtl" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2xtl.jpg|left|200px]] | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_2xtl", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_2xtl| PDB=2xtl | SCENE= }} | {{STRUCTURE_2xtl| PDB=2xtl | SCENE= }} | ||
| - | |||
===STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE=== | ===STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE=== | ||
| - | |||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_21593422}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 21593422 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_21593422}} | {{ABSTRACT_PUBMED_21593422}} | ||
| Line 22: | Line 7: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:021593422</ref><references group="xtra"/> | + | <ref group="xtra">PMID:021593422</ref><references group="xtra"/><references/> |
[[Category: Streptococcus agalactiae]] | [[Category: Streptococcus agalactiae]] | ||
[[Category: Bolognesi, M.]] | [[Category: Bolognesi, M.]] | ||
Revision as of 08:23, 8 May 2013
STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE
Template:ABSTRACT PUBMED 21593422
About this Structure
2xtl is a 2 chain structure with sequence from Streptococcus agalactiae. Full crystallographic information is available from OCA.
Reference
- Nuccitelli A, Cozzi R, Gourlay LJ, Donnarumma D, Necchi F, Norais N, Telford JL, Rappuoli R, Bolognesi M, Maione D, Grandi G, Rinaudo CD. From the Cover: Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections. Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10278-83. Epub 2011 May 18. PMID:21593422 doi:10.1073/pnas.1106590108
